MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, today opened its new 210,000 square-foot North American headquarters in Marlborough, Massachusetts. At full capacity in 2017, it will employ more than 500 scientists and professionals in the Boston area focused on accelerating precision medicine across a portfolio including:
- Manufacturing technologies for cell and immune therapies that are showing the potential to cure some of the world’s toughest diseases, such as cancer
- Early stage research tools used to develop the next generation of precision medicines
- Technologies and consumables for manufacturing vaccines, insulin and the rapidly growing new class of drugs known as biologics
- Leading-edge contrast agents and nuclear medicine tracers that clinicians use to diagnose disease
The new facility at 100 Results Way will be home to 40,000 square feet of laboratories supporting cell and immune therapy research and development, early stage drug development, biomanufacturing, as well as scientific and medical affairs support.
The laboratories will house GE’s ninth global Fast Trak facility, which partners with and trains biotech innovators to discover new drugs, develop manufacturing workflows, and optimize their biomanufacturing processes. In 2017, the site will also include GE’s FlexFactory manufacturing platform, originally designed in Marlborough, MA, and which pioneered end-to-end, flexible, small batch biologic drug manufacturing.
"General Electric's ongoing investment in Massachusetts is just the latest proof that the Commonwealth is a global leader in life science innovation, from discovery to manufacturing and commercialization," said Governor Charlie Baker. "With a deep bench of talent and supportive economic environment, we are excited to have GE Healthcare be a part of Central Massachusetts' growing workforce and look forward to the advances that will benefit the health and wellbeing of our citizens."
GE Healthcare’s nearby Westborough, MA, facility will continue to produce single-use products and consumables for biopharmaceutical manufacturing and with GE’s corporate headquarters moving to Boston this summer, by the end of 2016, GE will have nearly 5,000 employees across Massachusetts.
“Two years ago, we began to move our east coast North American operations to the Boston area to better coordinate our focus on patients, clinicians and customers’ needs,” said Kieran Murphy, president and CEO of GE Healthcare’s Life Sciences business. “Having our North American headquarters in the heart of Massachusetts’ rich ecosystem of healthcare, pharma, and biotech brings us closer to key customers, outstanding talent and ground-breaking innovation and is already helping fuel further growth for our business.”
###
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
About GE Healthcare Life Sciences
GE Healthcare's $4B Life Sciences business is on a mission is to accelerate an age of molecular and precision medicine by providing expertise, tools and solutions for a wide range of applications, including basic research of cells and proteins, drug discovery, cell therapy and regenerative medicine, as well as tools and technology to support large-scale manufacturing of biopharmaceuticals, vaccines and biologics such as insulin. It also supplies leading contrast, PET and nuclear medicine agents for diagnostic imaging to help doctors make more informed diagnoses for better patient outcomes. The company's mission is to help enable a new era of molecular and precision medicine by providing customers with the tools, insight and knowledge to guide them ever more quickly from better biological understanding to better clinical therapies.
